Literature DB >> 20842073

Co-occurrence of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women.

Megan Gatski1, David H Martin, Rebecca A Clark, Emily Harville, Norine Schmidt, Patricia Kissinger.   

Abstract

Trichomonas vaginalis (TV) and bacterial vaginosis (BV) were examined among human immunodeficiency virus+ women. The prevalence rates were 28.0% for TV, 51.4% for BV, and 17.5% for TV/BV co-infection. Among human immunodeficiency virus+/TV+ women, the rate of BV was 61.0%. Research is needed to examine how BV affects the clinical course and treatment of T. vaginalis.

Entities:  

Mesh：

Year:  2011        PMID： 20842073      PMCID： PMC3786582          DOI： 10.1097/OLQ.0b013e3181f22f56

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


  37 in total

1.  Association between trichomoniasis and bacterial vaginosis: examination of 600 cervicovaginal smears.

Authors:  S Demirezen; E Korkmaz; M S Beksaç
Journal:  Cent Eur J Public Health       Date:  2005-06       Impact factor: 1.163

2.  Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis.

Authors:  Beverly E Sha; M Reza Zariffard; Qiong J Wang; Hua Y Chen; James Bremer; Mardge H Cohen; Gregory T Spear
Journal:  J Infect Dis       Date:  2004-12-02       Impact factor: 5.226

3.  Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women.

Authors:  Beverly E Sha; Hua Y Chen; Qiong J Wang; M Reza Zariffard; Mardge H Cohen; Gregory T Spear
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Sexually transmitted diseases treatment guidelines, 2006.

Authors:  Kimberly A Workowski; Stuart M Berman
Journal:  MMWR Recomm Rep       Date:  2006-08-04

5.  Is the presence of Trichomonas on a Pap smear associated with an increased incidence of bacterial vaginosis?

Authors:  Debra S Heller; Svetlana Maslyak; Joan Skurnick
Journal:  J Low Genit Tract Dis       Date:  2006-07       Impact factor: 1.925

6.  Vaginal swabs versus lavage for detection of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women.

Authors:  Patricia J Kissinger; Jeanne Dumestre; Rebecca A Clark; Luann Wenthold; Hamish Mohammed; Michael E Hagensee; David H Martin
Journal:  Sex Transm Dis       Date:  2005-04       Impact factor: 2.830

7.  The occurrence of vaginal infections among HIV-infected and high-risk HIV-uninfected women: longitudinal findings of the women's interagency HIV study.

Authors:  D Heather Watts; Gayle Springer; Howard Minkoff; Sharon L Hillier; Lisa Jacobson; Michael Moxley; Jessica Justman; Helen Cejtin; Casey O'Connell; Ruth M Greenblatt
Journal:  J Acquir Immune Defic Syndr       Date:  2006-10-01       Impact factor: 3.731

8.  Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group.

Authors:  S Cu-Uvin; J W Hogan; D Warren; R S Klein; J Peipert; P Schuman; S Holmberg; J Anderson; E Schoenbaum; D Vlahov; K H Mayer
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

9.  Risk factors for bacterial vaginosis in pregnancy: a population-based study on Danish women.

Authors:  Poul Thorsen; Ida Vogel; Kirsten Molsted; Bo Jacobsson; Magnus Arpi; Birger R Møller; Bernard Jeune
Journal:  Acta Obstet Gynecol Scand       Date:  2006       Impact factor: 3.636

10.  Sexually transmitted disease acquisition among women infected with human immunodeficiency virus type 1.

Authors:  S J Bersoff-Matcha; M M Horgan; V J Fraser; L M Mundy; B P Stoner
Journal:  J Infect Dis       Date:  1998-10       Impact factor: 5.226
View more
  13 in total

1.  The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women.

Authors:  Megan Gatski; David H Martin; Judy Levison; Leandro Mena; Rebecca A Clark; Mary Murphy; Harold Henderson; Norine Schmidt; Patricia Kissinger
Journal:  Sex Transm Infect       Date:  2011-01-29       Impact factor: 3.519

2.  Mixed vaginitis-more than coinfection and with therapeutic implications.

Authors:  Jack D Sobel; Chitra Subramanian; Betsy Foxman; Marilyn Fairfax; Scott E Gygax
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

3.  Bacterial vaginosis and the risk of trichomonas vaginalis acquisition among HIV-1-negative women.

Authors:  Jennifer E Balkus; Barbra A Richardson; Lorna K Rabe; Taha E Taha; Nyaradzo Mgodi; Margaret Phiri Kasaro; Gita Ramjee; Irving F Hoffman; Salim S Abdool Karim
Journal:  Sex Transm Dis       Date:  2014-02       Impact factor: 2.830

Review 4.  Single-Dose Compared With Multidose Metronidazole for the Treatment of Trichomoniasis in Women: A Meta-Analysis.

Authors:  Katharine Howe; Patricia J Kissinger
Journal:  Sex Transm Dis       Date:  2017-01       Impact factor: 2.830

5.  Epidemiology and treatment of trichomoniasis.

Authors:  Patricia Kissinger
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

6.  Bacterial vaginosis and risk for Trichomonas vaginalis infection: a longitudinal analysis.

Authors:  Sujit D Rathod; Karl Krupp; Jeffrey D Klausner; Anjali Arun; Arthur L Reingold; Purnima Madhivanan
Journal:  Sex Transm Dis       Date:  2011-09       Impact factor: 2.830

7.  Novel structural features of the immunocompetent ceramide phospho-inositol glycan core from Trichomonas vaginalis.

Authors:  Christian Heiss; Zhirui Wang; Ian Black; Parastoo Azadi; Raina N Fichorova; Bibhuti N Singh
Journal:  Carbohydr Res       Date:  2015-11-10       Impact factor: 2.104

Review 8.  Modern diagnosis of Trichomonas vaginalis infection.

Authors:  Marcia M Hobbs; Arlene C Seña
Journal:  Sex Transm Infect       Date:  2013-04-30       Impact factor: 3.519

9.  Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.

Authors:  Patricia Kissinger; Christina A Muzny; Leandro A Mena; Rebecca A Lillis; Jane R Schwebke; Laura Beauchamps; Stephanie N Taylor; Norine Schmidt; Leann Myers; Peter Augostini; William E Secor; Martina Bradic; Jane M Carlton; David H Martin
Journal:  Lancet Infect Dis       Date:  2018-10-05       Impact factor: 25.071

10.  Hormonal Contraception and Vaginal Infections Among Couples Who Are Human Immunodeficiency Virus Serodiscordant in Lusaka, Zambia.

Authors:  Lisa B Haddad; Kristin M Wall; Katherine Tote; William Kilembe; Bellington Vwailika; Tyronza Sharkey; Ilene Brill; Elwyn Chomba; Amanda Tichacek; Susan Allen
Journal:  Obstet Gynecol       Date:  2019-09       Impact factor: 7.623
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.